What is the Impact Factor of Journal of Infection and Chemotherapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Infection and Chemotherapy is 1.70, ranking in quartile Q4 of Web of Science (SCIE).

Is Journal of Infection and Chemotherapy indexed in Web of Science or Scopus?

Yes, Journal of Infection and Chemotherapy is indexed in Web of Science (SCIE, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.503 (Q3) and an H-index of 79.

Who publishes Journal of Infection and Chemotherapy and what is the Article Processing Charge (APC)?

Journal of Infection and Chemotherapy is published by Springer Japan. The estimated Article Processing Charge (APC) is approximately $2,998 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Journal of Infection and Chemotherapy?

The official ISO-4 abbreviation of Journal of Infection and Chemotherapy is "J INFECT CHEMOTHER" with common acronym "jiche". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q4Scopus Q3SCImago #11,834Hybrid

Journal of Infection and Chemotherapy

Acronym:jiche

•

Abbreviation (ISO):J INFECT CHEMOTHER

•

Identifier (ISSN):1341-321X(Print)/1437-7780(Online)

•

Publisher:Springer Japan

Official Website Submission Portal Compare

Clarivate IF (2026)

1.7↑ +0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Infection and Chemotherapy

WoS Q4

Annual Impact Factor Metric

Current (2026):1.7

Scopus SJR & RankScopus Q3

0.503

#11,834

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

79 papers with at least that number of citations each

WoS: SCIE / JCRQ4

Self-Citation Rate5.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

325articles/year

11.06% Gold OA•94.66% Original Research

Aims & Scope

The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.

Topics Covered (Recognized by AI)

Biology96.5%Medicine94.1%Genetics84.7%Internal medicine72.4%Chemistry68.8%Microbiology66.1%Biochemistry65.1%Immunology51.7%Pathology50.3%Geology49.8%Paleontology49.7%Bacteria46.4%Surgery44.3%Antibiotics43.7%Virology37.4%Gene24%Organic chemistry23.7%Psychology20.5%

Primary Research Areas

Infectious Diseases Pharmacology & Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

INFECTIOUS DISEASES

Rank110/141

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank267/356

IndexSCIE

JCISCIE2026

INFECTIOUS DISEASES

Rank95/141

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank224/356

IndexSCIE

Category	Index	Rank	Quartile
INFECTIOUS DISEASES	JCRSCIE	110/141	Q4
PHARMACOLOGY & PHARMACY	JCRSCIE	267/356	Q3
INFECTIOUS DISEASES	JCISCIE	95/141	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	224/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.7

Articles / Year158

Total Citations32

2025

IF1.5

Articles / Year279

Total Citations398

2024

IF1.9

Articles / Year277

Total Citations780

2023

IF2.2

Articles / Year255

Total Citations1,234

2022

IF2.065

Articles / Year289

Total Citations2,305

Year	Impact Factor	Articles / Year	Total Citations
2026	1.7	158	32
2025	1.5	279	398
2024	1.9	277	780
2023	2.2	255	1,234
2022	2.065	289	2,305
2021	2.211	297	3,138
2020	—	294	3,938
2019	1.539	250	3,814
2018	1.777	204	3,895
2017	—	183	3,055
2016	—	178	3,622
2015	—	147	3,355

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,834Scopus Q3SCImago Profile

Scopus Coverage:1995-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q3

0.503

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.66

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,998 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,217

3-Year Documents756

Citable Documents745

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate27.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ3

Microbiology (medical)Q3

Pharmacology (medical)Q3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 5.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区INFECTIOUS DISEASES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Infection and Chemotherapy (acronym: jiche, abbr: J INFECT CHEMOTHER, ISSN: 1341-321X) is a peer-reviewed international scholarly journal in the field of INFECTIOUS DISEASES, published by Springer Japan in Japan since 1995. The periodical holds a Journal Impact Factor (JIF) of 1.70, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.503 (Q3), an H-index of 79.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 325 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,998 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.